HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BodySenseShop.com

This article was originally published in The Rose Sheet

Executive Summary

Body Sense, an online marketplace for personal-care products that are rated for safety according to Environmental Working Group's (EWG) Skin Deep Database, has announced launch of a new retail Web site 1www.BodySenseShop.com, targeted to "safety-conscious shoppers who don't want to compromise on quality," according to Oct. 16 release. Shoppers can browse among 200 different personal-care products from more than 30 manufacturers, all qualifying for lowest-hazard rating, 0-2, on 0-10 Skin Deep scale. Body Sense CEO Jerry Goldsmith touts site as "a one-stop shop for the safest personal-care products on the market." To help kick off retail site and to assist consumers who may be new to safety-rated personal care, BodySenseShop.com is currently offering a starter pack featuring 10 different personal-care products from nine suppliers - including Jason, Weleda and Skin Free - and a baby starter pack with six different products from five manufacturers, including Tom's of Maine and Isvara. Site features new products added on monthly basis, free travel-size shampoo with all purchases over $50 and regular audits of site's inventory to ensure products reflect changes to EWG product rating reports

You may also be interested in...



QUOTED. 26 February 2020. Mark Leahey.

In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.

UsernamePublicRestriction

Register

RS015725

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel